Published Date: 08 Mar 2023
At a trial in Georgia on Wednesday, three drug traffickers won a case brought by the family of a drug addict, accusing the company of selling drugs.
Read Full NewsFederal and state health officials are investigating 13 cases in 10 states of infant botulism linked to baby formula that was being recalled, authorities said Saturday.
In the United States, 1 in every 250 people has inherited a genetic variant that leads to dangerously high cholesterol levels from birth.
A study has found that people with eczema are able to bathe either daily or weekly, without any impact on their symptoms.
The risk of dying is six times higher among patients who become short of breath after being admitted to hospital, according to research published in ERJ Open Research. Patients who were in pain were not more likely to die.
A tailored approach of vitamin D3 supplementation in patients who have suffered a heart attack significantly reduces their risk of a second heart attack, a new study from heart researchers at Intermountain Health in Salt ...
A new study from researchers at Intermountain Health reveals that hypertensive disorders of pregnancy (HDP) significantly increase the risk of cardiovascular complications—including heart attack, stroke, heart failure, ...
In cases of mild congenital heart defects, more prenatal visits are associated with a greater likelihood of appropriate delivery at a community hospital, according to a study published in JAMA Network Open. Results suggest ...
1.
On all CAR-T products, the FDA is calling for a new boxed warning.
2.
If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version
3.
Data indicate 1 in 3 US adults unaware of connection between HPV and cancers
4.
In KRAS-mutated non-small cell lung cancer, glecirasib exhibits promising efficacy.
5.
CAR Natural Killer Cell Therapy Shows Promise in B-Cell Lymphomas
1.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
2.
The Statistical Frontier of Hematology Oncology: Diagnostics, Therapies, and Future Horizons in Hematology Oncology 2025
3.
Exploring the Latest Treatments for Essential Thrombocythemia
4.
Analyzing the Mechanisms and Efficacy of Carboplatin, Abraxane, and Albumin-Bound Formulations
5.
The Millionaire's Battle: Does Mark Cuban Have Cancer?
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Thromboprophylaxis In Medical Settings- An Update
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
5.
Navigating the Complexities of Ph Negative ALL - Part XVI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation